Center for Health Systems Innovation

Medicine & Life Sciences

1. Achilles Tendon 32%
2. Alkaline Phosphatase 9%
3. Amino Acids 10%
4. anti-Thy antibody 8%
5. Appointments and Schedules 8%
6. Area Under Curve 10%
7. Atrial Fibrillation 24%
8. Automobiles 29%
9. Breast Neoplasms 17%
10. Budesonide 11%
11. Chronic Obstructive Pulmonary Disease 24%
12. Clinical Decision-Making 8%
13. Cohort Studies 18%
14. Comorbidity 21%
15. Confidence Intervals 17%
16. Conjugated (USP) Estrogens 12%
17. Coronary Artery Disease 22%
18. Costs and Cost Analysis 8%
19. Cross-Sectional Studies 37%
20. Data Mining 41%
21. Datasets 16%
22. Decision Trees 27%
23. Delayed Hypersensitivity 30%
24. Delivery of Health Care 39%
25. Diabetic Neuropathies 31%
26. Diabetic Retinopathy 28%
27. Digoxin 32%
28. Diltiazem 32%
29. Dry Eye Syndromes 32%
30. Early Detection of Cancer 25%
31. Efficiency 24%
32. Electronic Health Records 72%
33. Escherichia coli K12 37%
34. Estradiol 7%
35. Fimbriae Proteins 81%
36. Fluorescein 8%
37. Fluticasone-Salmeterol Drug Combination 13%
38. Formoterol Fumarate 12%
39. Health 32%
40. Health Literacy 8%
41. Healthcare Disparities 9%
42. Hormone Replacement Therapy 30%
43. Hospital Emergency Service 28%
44. Hospital Mortality 28%
45. Insurance Coverage 7%
46. Length of Stay 8%
47. Logistic Models 16%
48. Lyt antibodies 9%
49. Machine Learning 30%
50. Marital Status 12%
51. Medicaid 19%
52. Medicare 11%
53. MEDLINE 18%
54. Membranes 32%
55. Meta-Analysis 81%
56. Mortality 22%
57. Nephrology 32%
58. Odds Ratio 20%
59. Organizational Efficiency 15%
60. Patient Care 7%
61. Patient Protection and Affordable Care Act 37%
62. Patient Readmission 31%
63. Patient-Centered Care 8%
64. Pediatrics 17%
65. Peptides 20%
66. Pharmaceutical Preparations 11%
67. Pharmacology 9%
68. Physicians 47%
69. Pneumocystis carinii 35%
70. Pneumocystis Infections 8%
71. Postoperative Nausea and Vomiting 34%
72. Primary Care Physicians 30%
73. Primary Health Care 60%
74. Proteins 9%
75. Psoriasis 26%
76. Quality Improvement 12%
77. Quality of Health Care 7%
78. Quality of Life 21%
79. Randomized Controlled Trials 21%
80. Research Personnel 10%
81. Rupture 23%
82. Sepsis 43%
83. Single Nucleotide Polymorphism 22%
84. Smokers 68%
85. Smoking 10%
86. Smoking Cessation 59%
87. Support Vector Machine 16%
88. Systematic Reviews 100%
89. Systemic Inflammatory Response Syndrome 36%
90. T-Lymphocyte Subsets 11%
91. Technology 8%
92. Therapeutics 14%
93. Transportation of Patients 16%
94. United States Health Resources and Services Administration 10%
95. Urban Hospitals 8%
96. Veterans 28%
97. Workflow 33%
98. Workforce 18%
99. Workload 40%
100. Wounds and Injuries 13%